Published: October 31st 2024 | Updated: December 14th 2024
AAO 2024: Fundus photography/OCT expediates care in the emergency department
Published: October 1st 2024 | Updated: December 14th 2024
EURETINA 2024: Ali Erginay, MD, speaks about Red-Blue-Green (RGB) imaging modalities
Published: May 23rd 2024 | Updated: December 14th 2024
US FDA issues approval for two aflibercept biosimilars
Published: July 2nd 2024 | Updated: December 14th 2024
FDA approves Formycon’s biosimilar to Eylea, aflibercept-mrbb (Ahzantive)
Published: July 3rd 2024 | Updated: December 14th 2024
Altos Biologics submits Marketing Authorization Application to the EMA for ALT-L9, an aflibercept biosimilar
Published: August 6th 2024 | Updated: December 14th 2024
Lupin's phase 3 trials for ranibizumab biosimilar reaches primary endpoint